September 4, 2024
TOPLINE: Nearly 80% of patients with metastatic uveal melanoma experienced skin toxicities with tebentafusp, a targeted immunotherapy, according to a study that also suggests that the […]
September 4, 2024
HUNTINGTON BEACH, Calif. — Mounting evidence suggests that using topical timolol to treat a pyogenic granuloma (PG) may spare children from undergoing a surgical procedure, especially […]
September 2, 2024
TOPLINE: The cumulative incidence of keratinocyte carcinomas (KCs) among childhood cancer survivors (CCS) over 20 years after diagnosis was 1.5% overall and among those exposed to […]
September 2, 2024
TOPLINE: A secondary analysis of a randomized trial shows that the impact of prenatal fish oil supplementation on the risk for childhood atopic dermatitis (AD) varies […]
September 2, 2024
TOPLINE: Black children with vitiligo are significantly more likely to be diagnosed with psychiatric disorders, including depression, suicidal ideation, and disruptive behavior disorders, than matched controls […]
August 30, 2024
TOPLINE: Mobile images may be reliable for assessing cutaneous neurofibroma (cNF) features in patients with neurofibromatosis type 1 (NF1), according to a crowdsourced registry study that […]
August 30, 2024
CARLSBAD, Calif. — After Arash Moradzadeh, MD, treated the first 100 consecutive patients in his practice with a 1726-nm laser (AviClear) following its Food and Drug […]
August 26, 2024
After years of debate and disagreement, could an improved, more user-friendly version of iPLEDGE be on the horizon? iPLEDGE, the US Food and Drug Administration (FDA)-required […]
August 26, 2024
TOPLINE: Zasocitinib, a tyrosine kinase 2 (TYK2) inhibitor, at oral doses of ≥ 5 mg led to greater skin clearance than placebo over a period of […]